1. Home
  2. MGX vs CULP Comparison

MGX vs CULP Comparison

Compare MGX & CULP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MGX
  • CULP
  • Stock Information
  • Founded
  • MGX 2018
  • CULP 1972
  • Country
  • MGX United States
  • CULP United States
  • Employees
  • MGX N/A
  • CULP N/A
  • Industry
  • MGX
  • CULP Textiles
  • Sector
  • MGX
  • CULP Consumer Discretionary
  • Exchange
  • MGX NYSE
  • CULP Nasdaq
  • Market Cap
  • MGX 62.1M
  • CULP 50.9M
  • IPO Year
  • MGX 2024
  • CULP N/A
  • Fundamental
  • Price
  • MGX $2.17
  • CULP $4.68
  • Analyst Decision
  • MGX Strong Buy
  • CULP
  • Analyst Count
  • MGX 4
  • CULP 0
  • Target Price
  • MGX $13.00
  • CULP N/A
  • AVG Volume (30 Days)
  • MGX 912.4K
  • CULP 24.3K
  • Earning Date
  • MGX 08-13-2025
  • CULP 09-03-2025
  • Dividend Yield
  • MGX N/A
  • CULP N/A
  • EPS Growth
  • MGX N/A
  • CULP N/A
  • EPS
  • MGX N/A
  • CULP N/A
  • Revenue
  • MGX $45,263,000.00
  • CULP $213,237,000.00
  • Revenue This Year
  • MGX N/A
  • CULP $9.97
  • Revenue Next Year
  • MGX $11.75
  • CULP $4.04
  • P/E Ratio
  • MGX N/A
  • CULP N/A
  • Revenue Growth
  • MGX N/A
  • CULP N/A
  • 52 Week Low
  • MGX $1.23
  • CULP $3.42
  • 52 Week High
  • MGX $5.50
  • CULP $6.85
  • Technical
  • Relative Strength Index (RSI)
  • MGX 71.83
  • CULP 74.17
  • Support Level
  • MGX $1.45
  • CULP $3.78
  • Resistance Level
  • MGX $2.47
  • CULP $4.80
  • Average True Range (ATR)
  • MGX 0.16
  • CULP 0.23
  • MACD
  • MGX 0.09
  • CULP 0.09
  • Stochastic Oscillator
  • MGX 75.47
  • CULP 95.24

About MGX METAGENOMI INC

Metagenomi Inc is a genetic medicines company committed to developing curative therapeutics for patients using its proprietary, comprehensive metagenomics-derived genome editing toolbox. The genome editing toolbox includes systems for making small edits such as programmable nucleases, base editors, small RNA-mediated integration systems (RIGS), as well as large gene integration systems including large template RIGS and CRISPR-associated transposases (CASTs). The company is focused on its vivo gene editing for its wholly-owned pipeline while pursuing technology out licensing for ex vivo cell therapy. Its pipeline includes product candidates aimed at addressing disorders like Hemophilia A (through MGX-001), Refractory Hypertension, Cardiovascular diseases, and Wilson's disease, among others.

About CULP Culp Inc.

Culp Inc manufactures, sources, and markets mattress fabrics and sewn covers used for covering mattresses and box springs and upholstery fabrics including cut and sewn kits used in the production of upholstered furniture. The company has two operating segments Mattress fabrics which generates maximum revenue, and Upholstery fabrics. The mattress fabrics segment, also known as Culp Home Fashions, manufactures and markets mattress fabrics and mattress covers to bedding manufacturers. The upholstery fabrics segment markets fabrics for residential, commercial, and hospitality furniture and also provides window treatment products and installation services for its customers in the hospitality and commercial industries. Geographically, it derives key revenue from the United States of America.

Share on Social Networks: